Please login to the form below

Not currently logged in
Email:
Password:

ACP-501

This page shows the latest ACP-501 news and features for those working in and with pharma, biotech and healthcare.

AZ boosts cardiovascular pipeline with US biotech acquisition

AZ boosts cardiovascular pipeline with US biotech acquisition

The deal gives AZ access to AlphaCore's ACP-501, a recombinant human lecithin-cholesterol acyltransferase (LCAT) enzyme. ... Last year a phase I clinical trial of ACP-501 in patients with stable atherosclerosis met the primary safety and tolerability

Latest news

More from news
Approximately 1 fully matching, plus 0 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Hanson Zandi

Hanson Zandi is a Creative and Digital Healthcare Agency. We combine 30 years’ experience with the enthusiasm of a start-up...

Latest intelligence

Alzheimer’s disease – is Europe prepared if a breakthrough treatment becomes available?
Healthcare leaders in the European Union should begin preparing for a breakthrough now...
The UK’s new five-year pricing agreement
Pharma has agreed to capped growth again - in exchange for uptake promises...
Digital applications are transforming the market access landscape
Organisations are leveraging new technology to implement a wider range of business models and, in essence, drive market access success by working smarter, faster and with greater economy....

Infographics